A Stock You Should Be Looking At: CorMedix Inc. (NASDAQ:CRMD)

After finishing at $3.90 in the prior trading day, CorMedix Inc. (NASDAQ: CRMD) closed at $3.99, up 2.31%. In other words, the price has increased by $+0.0900 from its previous closing price. On the day, 206320 shares were traded. CRMD stock price reached its highest trading level at $4.0400 during the session, while it also had its lowest trading level at $3.8400.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of CRMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.80 and its Current Ratio is at 11.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 17, 2021, initiated with a Buy rating and assigned the stock a target price of $31.

On September 29, 2020, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.

On September 21, 2020, Truist started tracking the stock assigning a Buy rating and target price of $20.Truist initiated its Buy rating on September 21, 2020, with a $20 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 when Todisco Joseph bought 20,000 shares for $3.82 per share. The transaction valued at 76,400 led to the insider holds 242,169 shares of the business.

Todisco Joseph bought 4,700 shares of CRMD for $18,424 on Aug 24. The Chief Executive Officer now owns 222,169 shares after completing the transaction at $3.92 per share. On May 17, another insider, Kaplan Myron, who serves as the Director of the company, bought 5,000 shares for $3.78 each. As a result, the insider paid 18,900 and bolstered with 160,034 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 1779.63 while its Price-to-Book (P/B) ratio in mrq is 2.91.

Stock Price History:

Over the past 52 weeks, CRMD has reached a high of $8.02, while it has fallen to a 52-week low of $2.64. The 50-Day Moving Average of the stock is 3.1636, while the 200-Day Moving Average is calculated to be 3.9413.

Shares Statistics:

The stock has traded on average 194.12K shares per day over the past 3-months and 373.31k shares per day over the last 10 days, according to various share statistics. A total of 41.18M shares are outstanding, with a floating share count of 40.77M. Insiders hold about 0.90% of the company’s shares, while institutions hold 26.80% stake in the company. Shares short for CRMD as of Oct 13, 2022 were 1.56M with a Short Ratio of 1.64M, compared to 1.62M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.78% and a Short% of Float of 3.81%.

Earnings Estimates

Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.2 and a low estimate of -$0.25, while EPS last year was -$0.22. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.3.

Analysts are recommending an EPS of between -$0.77 and -$0.92 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$0.91, with 3 analysts recommending between -$0.7 and -$1.08.